An oral relaxin agonist developed by AstraZeneca, codenamed AZD5462, has been shown to improve cardiac function in patients ...

Takeda and Protagonist Therapeutics' hepcidin mimetic rusfertide has been approved by the FDA to treat polycythaemia vera (PV ...

South Korea’s mRNA ecosystem is rapidly advancing, fueled by progress from companies like GC Biopharma and EyeGene in ...

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s ...

The new acquisition is Lilly's ninth since the start of the year, coming just a few weeks after it agreed to buy psychedelic ...

Through increased government investment in AI and in silico technologies, and prominent partnerships and milestones from companies like 1st Biotherapeutics, Galux, Hanmi Pharm, and LG Research AI, ...

Cytokinetics has revealed the highly anticipated data from the ACACIA-HCM study of Myqorzo, which promises to take the cardiac myosin inhibitor into new territory for the class. First teased in May, ...

A new, universal definition for a heart attack or myocardial infarction (MI) recognises that there are many different ...

Since taking effect in August 2024, the EU AI Act (Regulation (EU) 2024/1689) has categorised AI tools by risk level. For ...

Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its innovative medicines and cell therapy businesses, which will result in the loss of around 300 jobs or ...

A digital therapy that could reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use by the NHS for the first time. The technology, known as ORBIT (Online ...

The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...